Xilis is an oncology and precision health company that provides technologies to diagnoses cancer.
Xilis has raised $19.4M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in April 2025.
Xilis's investors include Pear VC, 8VC, FPV Ventures, EQT, Felicis.
Xilis is headquartered in Durham, United States.
Xilis is an oncology and precision health company that provides technologies to diagnoses cancer.
Xilis is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Xilis — Funding & Investors." VCBacked, April 25, 2025, https://www.vcbacked.co/company/xilis. Accessed September 30, 2026.
VCBacked. (2025). Xilis — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/xilis
{{cite web |title=Xilis — Funding & Investors |url=https://www.vcbacked.co/company/xilis |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated